Pourlak Tala, Arani Seyyed Hamed Sharif, Abediazar Sima, Kafil Hossein Samadi
Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Pharmaceutical Nanotechnology Research Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Biomedicine (Taipei). 2021 Jun 1;11(2):18-23. doi: 10.37796/2211-8039.1118. eCollection 2021.
IgAN occurs following abnormal IgA deposition in the glomerular mesangial regions. It is the most common primary glomerular disease and one of the causes of ESRD, so it is necessary to identify clinical and histopathological findings that predict progression to ESRD. In the physiopathology of this disease, Cd causes serious renal injuries and should be counted as a significant prognostic factor too. This study examined Cd biomarker and compare it with findings affecting prognosis, to determine the predictive value of Cd in progression to ESRD in IgAN.
In this study, all biopsy samples of IgAN patients who referred to Imam Reza Hospital in Tabriz were collected for four years. Their samples were evaluated Cd immunohistochemical staining and positive samples have compared with Clinical-histopathological findings affecting prognosis.
In this study, Cd positivity showed a significant association with mesangial hypercellularity (p = 0.001), segmental glomerulosclerosis (p = 0.003), and endocapillary hypercellularity (p = 0.001); however, it did not show a significant relationship with tubular atrophy/interstitial fibrosis (p = 0.08). The study also found that Cd positivity was significantly (p < 0.05) correlated with hypertension, increased proteinuria, hematuria, high creatinine, and decreased mean eGFR.
This study showed that immunohistochemical staining of Cd is a useful method for evaluating the prognosis of the severity of renal injuries in patients with IgAN and could be a valuable alternative for most Clinical-histopathological factors routinely used as predictive factors for its progression to ESRD, especially when the biopsy specimen size is small and insufficient for other studies.
IgA肾病是在肾小球系膜区出现异常IgA沉积后发生的。它是最常见的原发性肾小球疾病,也是终末期肾病的病因之一,因此有必要确定可预测进展至终末期肾病的临床和组织病理学表现。在该疾病的病理生理学中,镉会导致严重的肾损伤,也应被视为一个重要的预后因素。本研究检测了镉生物标志物,并将其与影响预后的结果进行比较,以确定镉在IgA肾病进展至终末期肾病中的预测价值。
在本研究中,收集了四年来转诊至大不里士伊玛目礼萨医院的IgA肾病患者的所有活检样本。对其样本进行镉免疫组化染色评估,阳性样本与影响预后的临床组织病理学结果进行比较。
在本研究中,镉阳性与系膜细胞增多(p = 0.001)、节段性肾小球硬化(p = 0.003)和毛细血管内细胞增多(p = 0.001)显著相关;然而,它与肾小管萎缩/间质纤维化无显著关系(p = 0.08)。该研究还发现,镉阳性与高血压、蛋白尿增加、血尿、高肌酐和平均估算肾小球滤过率降低显著相关(p < 0.05)。
本研究表明,镉免疫组化染色是评估IgA肾病患者肾损伤严重程度预后的有用方法,对于大多数常规用作其进展至终末期肾病预测因素的临床组织病理学因素而言,它可能是一种有价值的替代方法,尤其是当活检标本量小且不足以进行其他研究时。